Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Hypertension

Systemic thinking, individualized treatment

    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • RX
    • Studies
  • 3 minute read

Hypertension is a widespread disease that primarily affects people of advanced age. Reducing levels to the target range requires comprehensive treatment management consisting of lifestyle modification and pharmacotherapy. If this approach does not lead to the desired success, recent study results show that interventional treatment can also be performed safely.

High blood pressure is a widespread disease, affecting around 18% of the population in Switzerland. The risk of hypertension increases with age. Therefore, Prof. Dr. med. Joachim Weil, Lübeck (D), pursued the question of what influence the environment as well as lifestyle changes can have on the disease. In addition to the environment, genetic and social determinants play a major role in the development of hypertension. Regarding the environment, air pollution is actually a common cause of premature death – five million people die prematurely worldwide due to increased particle pollution. Inhalation of polluted particles leads to oxidative stress, which has effects on the body in the form of autoimmune imbalance or endothelial dysfunction, among others. Systemic inflammation and thromboembolic events can also be attributed to air pollution. The result is cardiovascular events, the expert said. But it also increases the risk of hypertension by about 10%, data show.

Lowering blood pressure levels through lifestyle changes is the first step in the right direction. Appropriate measures include restrictive salt consumption, implementation of a DASH diet, weight reduction, exercise, and abstaining from alcohol consumption. According to studies, improved blood pressure values can certainly be achieved in this way – but as a rule, drug interventions are still necessary to reach the desired target range, summarized the expert.

Individualized therapy management

In addition to lifestyle modification, drug treatment should be individualized and take into account age, overall cardiovascular risk, comorbidities, and tolerability of therapy. Recommended initial treatment goal is to lower blood pressure to <140/90 mmHg in all patients. If drug management is well tolerated, values of 130/80 mmHG or lower should then be aimed for, as Prof. Oliver Dörr, MD, Giessen (D), pointed out. In elderly patients 65 years and older, SBP should be in the range of 130-139 mmHg. The guidelines recommend the dual combination of ACEi or ARB in combination with CCB or diuretic as initial therapy (Fig. 1) . The combination should be administered as a single pill, as this has been shown to increase adherence, Dörr emphasized. Monotherapy is indicated only in very old, frail sufferers over 80 years of age and low-risk patients with grade 1 hypotension. Therapy escalation to a triple combination should also be administered in a fixed combination. This consists of an ACEi or ARB plus CCB and diuretic. Resistant hypertension requires referral to a specialized center for further evaluation. As a rule, spironolactone is then added to the triple combination. Beta-blockers can be combined at any therapeutic level if there is a specific indication for their use.

Focus on interventional treatment

In addition to lifestyle modification and individualized pharmacotherapy, modern antihypertensive therapy includes a third pillar – interventional treatment. As Prof. Dr. med. Felix Mahfoud, Homburg (D), explained, some study results regarding device-based treatment have been published recently. No increased safety risk was detected in a total of 1174 patients. A recent ESC Consensus Statement therefore concludes that renal denervation should be considered for adult hypertensives with uncontrolled, resistant disease when long-term drug therapy is not tolerated. However, the general CV risk should be elicited in advance.

Source: “Thinking systemically and treating individually in hypertension,” April 24, 2023, 10:45-12:00, DGIM 2023.

Literature:

  1. Williams B, et al.: J Hypertens 2018; 36: 1953–2041.

HAUSARZT PRAXIS 2023; 18(6): 45

Autoren
  • Leoni Burggraf
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Hypertension
  • Hypertension
  • Widespread disease
Previous Article
  • Neuro-Oncology

The therapy of brain tumors in the light of new findings

  • Congress Reports
  • Neurology
  • Oncology
  • Radiology
  • RX
  • Studies
  • Surgery
  • Unkategorisiert
View Post
Next Article
  • IBD matters: Module four

Molecular mechanisms in pathogenesis and treatment.

  • RX
  • Allergology and clinical immunology
  • CME continuing education
  • Gastroenterology and Hepatology
  • General Internal Medicine
  • Studies
  • Training with partner
View Post
You May Also Like
View Post
  • 4 min
  • Case report: Drug-induced hepatitis

Rare side effect of tirzepatide therapy

    • Cases
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Plea for sex-specific neurology

Migraine in men: underdiagnosed, underestimated, under-researched

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 4 min
  • Prurigo nodularis

Retrospective analyses of large data sets from everyday practice

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
View Post
  • 3 min
  • Public Health

Outpatient care in Switzerland: situation report

    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • RX
View Post
  • 5 min
  • Practice Management

Improved quality of care aims for satisfied patients

    • CME continuing education
    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 30 min
  • Chemsex - MSM, sex, chrystal meth & co.

Medical and psychosocial perspectives

    • CME continuing education
    • General Internal Medicine
    • Infectiology
    • Pharmacology and toxicology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
View Post
  • 3 min
  • Bladder cancer

Tuberculosis vaccination reduces recurrences

    • Congress Reports
    • Oncology
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
    • Urology
View Post
  • 4 min
  • Oral JAK-i in atopic dermatitis

Benefits and risks: What does the current data say?

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.